Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06333054Completed
Randomised, single-blind trial (2 arms), sponsored by Oystershell. Primary endpoint: Cure Rate superior to 70% for the test product at Day 10. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06333054.